PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbacteremia
MeSH D016470 - bacteremia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001424:Bacterial infections
$
Success rate
D018805:Sepsis
$
Success rate
D016470: 
Bacteremia
D006483:Hemorrhagic septicemia
0 Companies
0 Drugs
Success rate
D019446:Endotoxemia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDaptomycin Daptomycin  2016-03-25   
PadagisBacitracin, Polymyxin b Bacitracin Polymyxin B  2002-02-27   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Bacitracin  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
MylanDaptomycin Daptomycin  2018-06-05   
GSKPolymyxin b Aerosporin  1982-01-01   
Neomycin, Polymyxin b Neosporin  1985-01-14   
Bacitracin, Polymyxin b Polysporin  1985-03-01   
SandozDexamethasone, Neomycin, Polymyxin b Maxitrol  1984-05-22   
Hydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1983-08-25   
Tigecycline Tigecycline  2015-05-27   
Trimethoprim, Polymyxin b Trimethoprim Polymyxin B  1998-04-13   
NovartisDexamethasone, Neomycin, Polymyxin b Dexacidin  1984-10-29   
Bausch Health CompaniesBacitracin, Polymyxin b Bacitracin Polymyxin B  1995-01-26   
Dexamethasone, Neomycin, Polymyxin b Dexasporin  1995-09-13   
Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Bacitracin  1995-10-30   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1994-07-25   
Gramicidin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Gramicidin  1996-01-31   
Hydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  1995-12-29   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone  1995-10-30   
Hydrocortisone, Neomycin, Polymyxin b Oticair  1996-08-28   
Trimethoprim, Polymyxin b Trimethoprim Polymyxin B  1997-02-14   
Merck Sharp & DohmeDaptomycin Cubicin  2006-01-19 $152 M Y2020 
Hydrocortisone, Neomycin, Polymyxin b Otobione  1982-01-01   
Hydrocortisone, Polymyxin b Otobiotic  1982-01-01   
AllerganPrednisolone, Neomycin, Polymyxin b Poly-pred  1982-01-01   
Trimethoprim, Polymyxin b Polytrim  1988-10-20   
Neomycin, Polymyxin b Neomycin Polymyxin B  1986-04-08   
Gramicidin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Gramicidin  1987-06-11   
Hydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
PfizerChloramphenicol, Polymyxin b Chloromyxin  1982-01-01   
Daptomycin Daptomycin Hospira  2017-03-22   
Oxytetracycline, Polymyxin b Terramycin W/ Polymyxin  1982-01-01   
Oxytetracycline, Polymyxin b Terramycin-polymyxin  1982-01-01   
Tigecycline Tygacil  2006-04-24 $202 M Q4/18-Q3/21 
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
75%
3/4
Phase 2
84%
16/19
Phase 3
43%
20/47
Approved: 6Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Bausch Health Companies
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use